(Q33805257)

29 July 2017

1 reference

title

A common set of factors control the expression of the MHC class II, invariant chain, and HLA-DM genes (English)

1 reference

29 July 2017

J M Boss

1

1 reference

PubMed ID

10614001

29 July 2017

language of work or name

1 reference

1 September 1999

1 reference

29 July 2017

Microbes and Infection

1 reference

29 July 2017

1

1 reference

29 July 2017

847-853

1 reference

29 July 2017

11

1 reference

Reactivation by a trans-acting factor of human major histocompatibility complex Ia gene expression in interspecies hybrids between an Ia-negative human B-cell variant and an Ia-positive mouse B-cell lymphoma

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900234-8

7 January 2021

Class II-antigen-negative patient and mutant B-cell lines represent at least three, and probably four, distinct genetic defects defined by complementation analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900234-8

7 January 2021

Regulation of transcription of MHC class II genes

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900234-8

7 January 2021

Regulation of a transfected human class II major histocompatibility complex gene in human fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900234-8

7 January 2021

The MHC class II transactivator (CIITA) requires conserved leucine charged domains for interactions with the conserved W box promoter element.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900234-8

7 January 2021

Class II transactivator regulates the expression of multiple genes involved in antigen presentation

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900234-8

7 January 2021

Reactivation of a major histocompatibility complex class II gene in mouse plasmacytoma cells and mouse T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900234-8

7 January 2021

Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900234-8

7 January 2021

Molecular analysis of G1B and G3A IFN gamma mutants reveals that defects in CIITA or RFX result in defective class II MHC and Ii gene induction

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900234-8

7 January 2021

Invariant chain structure and MHC class II function

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900234-8

7 January 2021

A trans-acting class II regulatory gene unlinked to the MHC controls expression of HLA class II genes

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900234-8

7 January 2021

Formaldehyde cross-linking and immunoprecipitation demonstrate developmental changes in H1 association with transcriptionally active genes

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900234-8

7 January 2021

A multiplicity of CCAAT box-binding proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900234-8

7 January 2021

RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900234-8

7 January 2021

RFX proteins, a novel family of DNA binding proteins conserved in the eukaryotic kingdom

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900234-8

7 January 2021

Binding and cooperative interactions between two B cell-specific transcriptional coactivators.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900234-8

7 January 2021

The class II trans-activator CIITA interacts with the TBP-associated factor TAFII32

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900234-8

7 January 2021

Identification of a trans-acting function regulation HLA-DR expression in a DR-negative B cell variant

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900234-8

7 January 2021

The RFX complex is crucial for the constitutive and CIITA-mediated transactivation of MHC class I and beta2-microglobulin genes

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900234-8

7 January 2021

Site alpha is crucial for two routes of IFN gamma-induced MHC class I transactivation: the ISRE-mediated route and a novel pathway involving CIITA

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900234-8

7 January 2021

Two B cell factors bind the HLA-DRA X box region and recognize different subsets of HLA class II promoters

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900234-8

7 January 2021

A signature motif in transcriptional co-activators mediates binding to nuclear receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900234-8

7 January 2021

The DNA-binding defect observed in major histocompatibility complex class II regulatory mutants concerns only one member of a family of complexes binding to the X boxes of class II promoters

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900234-8

7 January 2021

Properties of a CCAAT box-binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900234-8

7 January 2021

Complex architecture of major histocompatibility complex class II promoters: reiterated motifs and conserved protein-protein interactions

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900234-8

7 January 2021

In vivo footprinting of MHC class II genes: bare promoters in the bare lymphocyte syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900234-8

7 January 2021

Involvement of CREB binding protein in expression of major histocompatibility complex class II genes via interaction with the class II transactivator

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900234-8

7 January 2021

Histone acetyltransferase activity of yeast Gcn5p is required for the activation of target genes in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900234-8

7 January 2021

Active suppression of major histocompatibility complex class II gene expression during differentiation from B cells to plasma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900234-8

7 January 2021

A new member of the leucine zipper class of proteins that binds to the HLA DR alpha promoter

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900234-8

7 January 2021

Distinct cloned class II MHC DNA binding proteins recognize the X box transcription element

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900234-8

7 January 2021

Interferon (IFN) beta acts downstream of IFN-gamma-induced class II transactivator messenger RNA accumulation to block major histocompatibility complex class II gene expression and requires the 48-kD DNA-binding protein, ISGF3-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900234-8

7 January 2021

MHC class II-deficient combined immunodeficiency: a disease of gene regulation

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900234-8

7 January 2021

Transactivation by CIITA, the type II bare lymphocyte syndrome-associated factor, requires participation of multiple regions of the TATA box binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900234-8

7 January 2021

Role of the CCAAT-binding protein CBF/NF-Y in transcription

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900234-8

7 January 2021

Induction of MHC class I expression by the MHC class II transactivator CIITA.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900234-8

7 January 2021

A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900234-8

7 January 2021

Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900234-8

7 January 2021

CREB regulates MHC class II expression in a CIITA-dependent manner

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900234-8

7 January 2021

MHC class II gene silencing in trophoblast cells is caused by inhibition of CIITA expression

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900234-8

7 January 2021

RFX-B is the gene responsible for the most common cause of the bare lymphocyte syndrome, an MHC class II immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900234-8

7 January 2021

Human X-box-binding protein 1 is required for the transcription of a subset of human class II major histocompatibility genes and forms a heterodimer with c-fos

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900234-8

7 January 2021

Congenital immunodeficiency with a regulatory defect in MHC class II gene expression lacks a specific HLA-DR promoter binding protein, RF-X.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900234-8

7 January 2021

Function of major histocompatibility complex class II promoters requires cooperative binding between factors RFX and NF-Y

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900234-8

7 January 2021

DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900234-8

7 January 2021

Developmental extinction of major histocompatibility complex class II gene expression in plasmocytes is mediated by silencing of the transactivator gene CIITA.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900234-8

7 January 2021

Three classes of mutations in the A subunit of the CCAAT-binding factor CBF delineate functional domains involved in the three-step assembly of the CBF-DNA complex

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900234-8

7 January 2021

A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome)

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900234-8

7 January 2021

Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome)

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900234-8

7 January 2021

Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA.

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900234-8

7 January 2021

Regulation of MHC gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900234-8

7 January 2021

The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900234-8

7 January 2021

Orientation and positional mapping of the subunits of the multicomponent transcription factors RFX and X2BP to the major histocompatibility complex class II transcriptional enhancer

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900234-8

7 January 2021

CIITA stimulation of transcription factor binding to major histocompatibility complex class II and associated promoters in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900234-8

7 January 2021

In vivo footprint analysis of the HLA-DRA gene promoter: cell-specific interaction at the octamer site and up-regulation of X box binding by interferon gamma

1 reference

https://api.crossref.org/works/10.1016%2FS1286-4579%2899%2900234-8

7 January 2021

10.1016/S1286-4579(99)00234-8

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10614001